Literature DB >> 7104337

Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells.

W J Van Blitterswijk, G De Veer, J H Krol, P Emmelot.   

Abstract

The lipid fluidity in purified plasma membranes (PM) of murine leukemic GRSL cells, as measured by fluorescence polarization, is much higher than in PM of normal thymocytes. This was found to be due to relatively low contents of cholesterol and sphingomyelin and a high amount of unsaturated fatty acyl chains, especially linoleic acid, in the phospholipids. PM from GRSL cells contain markedly more phosphatidylethanolamine than those from thymocytes. For both GRSL cells and thymocytes the detailed lipid composition of isolated PM was compared with that of the corresponding shed extracellular membranes (ECM), which were isolated from the ascites fluid and from thymus cell suspensions, respectively. The somewhat decreased lipid fluidity of thymocyte ECM as compared to their PM, can be ascribed to the increased cholesterol/phospholipid molar ratio (0.88 vs. 0.74). No other major differences were found between the lipid composition of these membranes. In contrast, significant differences were found between PM and ECM from GRSL cells. In this system a much lower lipid fluidity of the shed ECM was found, due to the much increased cholesterol/phospholipid molar ratio (3.5-fold) and sphingomyelin (9-fold) content, as compared to the PM. Further, the ECM contain relatively more lysophosphatidylethanolamine and less phosphatidylcholine and -inositol. ECM contain a higher amount of polyunsaturated fatty acids, especially in the phosphatidylethanolamine and lysophosphatidylethanolamine classes. On the other hand, the fatty acids of phosphatidylcholine and lysophosphatidylcholine are more saturated than in PM. In particular, ECM of GRSL cells contain less oleic and linoleic acid residues and more arachidonic acid and 22:polyunsaturated fatty acid residues than PM. The possible relevance of these differences with respect to the mechanism of shedding of vesicles from the cell surface, is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104337     DOI: 10.1016/0005-2736(82)90361-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line.

Authors:  Eva Ogorevc; Samo Hudoklin; Peter Veranič; Veronika Kralj-Iglič
Journal:  Protoplasma       Date:  2013-09-10       Impact factor: 3.356

2.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 3.  Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake.

Authors:  Erik R Abels; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.046

4.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Investigation of malignancy-related glycopeptides and their release in vitro and in vivo from ascites tumour cells.

Authors:  E Walsh; H Smyth; A Corrigan
Journal:  Ir J Med Sci       Date:  1985-08       Impact factor: 1.568

6.  Membrane-targeted nanotherapy with hybrid liposomes for tumor cells leading to apoptosis.

Authors:  Yuji Komizu; Sayuri Nakata; Koichi Goto; Yoko Matsumoto; Ryuichi Ueoka
Journal:  ACS Med Chem Lett       Date:  2011-01-13       Impact factor: 4.345

7.  Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Authors:  V Dolo; S D'Ascenzo; S Violini; L Pompucci; C Festuccia; A Ginestra; M L Vittorelli; S Canevari; A Pavan
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

8.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

Authors:  T Eichholtz; K Jalink; I Fahrenfort; W H Moolenaar
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

Authors:  V Dolo; E Adobati; S Canevari; M A Picone; M L Vittorelli
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

10.  Microglial microvesicle secretion and intercellular signaling.

Authors:  Elena Turola; Roberto Furlan; Fabio Bianco; Michela Matteoli; Claudia Verderio
Journal:  Front Physiol       Date:  2012-05-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.